one known interaction is that bremelanotide can slow gastric emptying and thus potentially affect the absorption of oral medications (for example, it can reduce how well an oral antibiotic or naltrexone is absorbed)
May reduce efficacy of thyroid hormone replacement when co-administered
Pharmacol Res 160:105197
REDEFINE is an ongoing phase 3 trial acting as market evaluation for both CagriSema and cagrilintide, with 60% randomised to CagriSema, 10% cagrilintide, 10% semaglutide, and 20% placebo, where minimum age at inclusion was 55 years with no upper limit [117]
EMA (2014)
Consequently, the composition of an individuals microbiota is shaped by factors such as age, sex, ethnicity, and geographical region, resulting in a uniquely personalized GI microbial ecosystem (212)